bpc 157 crohn's disease If you have Crohn’s or colitis, you may have seen being promoted for gut healing., It is popular, but the human IBD evidence is still very limited and I don’t recommend it. In July 2026, the I have been asked many

In SURMOUNT-1 , a 72-week Phase 3 double-blind trial in 2,539 adults with obesity (or overweight with a complication) but without diabetes, once-weekly tirzepatide produced mean weight changes of 15.0% (5 mg), 19.5% (10 mg), and 20.9% (15 mg) versus 3.1% with placebo, with 5057% of participants on the higher doses losing at least 20% of body weight

How do you know what dose I require, can I have too much

For Underweight Individuals: Focus on consuming enough calories and nutrient-dense foods to reach a healthy weight

Look for a clinic with positive feedback and satisfied patients who have undergone stem cell treatment for similar conditions

Older individuals often have reduced nitric oxide production, stiffer blood vessels, and altered responses to vasoactive compounds

The product has contraindications